Schedule 13D ownership disclosure
Castle Biosciences Inc
Security class unavailable · CUSIP: 14843C105
Event date: 2020-10-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 983,577
- Percent of class
- 4.9970%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-113590
- Form type
- SC 13D
- Filer
- CASTLE BIOSCIENCES INC
- CIK
- CIK 1447362
- Filed
- Oct 09, 2020
- Reporting period
- Oct 05, 2020
- Description
- Schedule 13D beneficial ownership